%20(1).png)
Week 1
Starting dose
You begin at the lowest dose on purpose. Appetite changes are usually the first thing people notice. Nausea, if it comes, tends to show up here.
Physician-led weight loss programs, prescribed by board-certified physicians after a genuine medical review. Delivered to your door each month. Injection or dissolvable tablet.
“The consult was an actual conversation, not a form. She talked me out of the option I came in asking for.”
“Every dose is included, so I stopped bracing for the price to jump when I moved up.”
“Hablo poco ingles y todo el proceso fue en espanol. Eso lo cambio todo.”
Most of this category runs on intake forms that approve everyone. That is not what this is. A board-certified physician reviews your history, decides whether treatment is appropriate, chooses the program, and sets the starting dose. Sometimes the answer is no.
Which program you receive is determined by your prescriber based on your history and your labs. Format is a conversation you have with them, and it changes what it costs and where we can ship it.
Our most prescribed program and the usual starting point, acting on a single receptor pathway.
A dual-receptor program, considered when clinically appropriate or when the first program plateaus.
Prices include the physician consultation, medication, all doses, monthly delivery, weekly check-ins, and dose adjustments. A prescription is issued only if a licensed physician determines treatment is appropriate for you. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. First-month pricing is for new patients on injectable programs only.
Dissolvable tablets remove that objection entirely. Same physician review, same weekly check-ins, same dose adjustments, no injection. Available in Colorado, Florida, Pennsylvania, Wisconsin, and Wyoming to start.
Same camera, same distance, same light, same wall. Nothing retouched, nothing composited. Move between week zero and today at your own pace.
“The check-ins are what kept me on it. Somebody actually noticed when I stalled.”
Placeholder patients for design review. Individual results vary and are not guaranteed. Replace with consented patient photography and verified figures before publication.
Set your starting weight and height. The projection uses published clinical trial averages for GLP-1 and dual GIP/GLP-1 therapy. It illustrates what the research found. It is not a promise about you.
BMI is one of several things a physician reviews, not a decision on its own. Programs of this kind are generally considered at a BMI of 30 and above, or 27 and above alongside a weight-related condition. Wording and thresholds require clinical and legal sign-off.
Percentages reflect average total body weight reduction reported in published clinical trials of GLP-1 and dual GIP/GLP-1 therapy, alongside a reduced-calorie diet and increased physical activity. They are not outcomes measured in this practice. Every figure requires clinical and legal sign-off, and this module may need to be removed entirely.
Illustrative only. Not a medical prediction, diagnosis, or guarantee of outcome. Your physician determines whether treatment is appropriate and what results are realistic for you. Individual results vary substantially.
Talk to the care team about your history, your goals, and whether prescription treatment makes sense for you. No charge, no obligation, no card required.
A board-certified physician reads your intake and decides whether to prescribe, which program, which format, and at what starting dose. If treatment is not right for you, they will say so.
Medication ships monthly from a US-licensed pharmacy with every dose included. Weekly check-ins track how you are responding, and your dose moves with you rather than on a schedule.
Most people quit in month one because nobody told them what was normal. So here it is.
You begin at the lowest dose on purpose. Appetite changes are usually the first thing people notice. Nausea, if it comes, tends to show up here.
Side effects generally ease as your body adjusts. Your first check-in asks what you felt and whether you are eating and drinking enough.
Enough data now to see a trend rather than a fluctuation. Weight moves slowly at the starting dose, and that is expected.
Your prescriber decides whether to hold or step up, based on response and tolerance. Stepping up costs nothing extra. Holding is not a setback.
General information, not medical advice, and not a description of what will happen to you. Your experience depends on your history, your dose, and how you respond. Placeholder content pending clinical review.
Everything the program needs is in the monthly price. Here is what that covers, and what it does not.
Placeholder content for design review. Confirm every line against current operations, including the cancellation notice period, before publication.
The category is full of intake forms that approve everyone and subscriptions built to be hard to leave. There is a licensed physician between you and this prescription, and their answer is sometimes no.
Board-certified physicians read every intake. Eligibility is clinical, and not everyone qualifies.
One monthly price with every dose included. No membership fee, and no upcharge when your dose increases.
Weekly check-ins, dose adjustments, side-effect management. The prescription is the start, not the product.
No. This is a cash-pay practice and we do not bill insurance. The monthly price covers the physician consultation, the medication, all doses, and ongoing clinical care. HSA and FSA cards are accepted.
GLP-1 + B12 acts on one receptor pathway and includes vitamin B12. GLP-1/GIP + B3 acts on two receptor pathways and includes B3. Which is appropriate depends on your medical history, tolerance, and goals, and your physician makes that recommendation during your review.
Injections are a weekly self-administered shot and are available in 49 states, everywhere except New York. Dissolvable tablets go under the tongue and are currently available in Colorado, Florida, Pennsylvania, Wisconsin, and Wyoming. Tablets are priced as a flat monthly rate with no first-month special.
Yes. Your price does not change when your dose increases, and there is no separate membership fee on top of it.
No, and that is intentional. A board-certified physician reviews your medical history and decides whether treatment is appropriate for you. If it is not, they will tell you and you will not be charged for medication.
The most commonly reported effects are nausea, vomiting, diarrhea, constipation, and abdominal discomfort, most often when starting or increasing a dose. Serious risks exist and are reviewed with you before you start. Full safety information is provided with your prescription.
Yes, with notice. There is no long-term contract. See the terms for the required notice period.
Side effects are common, particularly in the first weeks and after each dose increase. Knowing that in advance is the difference between managing it and quitting.
Placeholder safety content for design review. It is incomplete and must be replaced with the full approved safety language, including boxed warnings and contraindications, before publication. GLP-1 receptor agonists may cause serious side effects including thyroid C-cell tumors in rodent studies. Do not use if you or a family member has a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
La consulta, las revisiones semanales y los mensajes con su equipo de atencion, todo disponible en espanol. No necesita traductor ni seguro medico.
This tells us where you are and what to talk about. It does not decide anything. A physician does that, after reading your full history.
Prescribing is state-specific, so this determines which formats are available to you.
Fifteen minutes with the care team. No charge, no obligation. You will know whether this is right for you before you pay anything.
Physician-led weight loss care. LegitScript certified telehealth.
Important safety information. GLP-1 receptor agonists may cause serious side effects, including thyroid C-cell tumors in rodent studies. Do not use if you or a family member has a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your physician about all medical conditions and medications before starting treatment. This is placeholder text and must be replaced with the full approved safety language before launch.
Availability. Injectable programs are available to patients located in 49 states and are not available in New York. Dissolvable tablet programs are available only to patients located in Colorado, Florida, Pennsylvania, Wisconsin, and Wyoming. Availability is subject to change and is determined by where treatment can lawfully be prescribed and dispensed.
Pricing. Prices shown are per month and include the physician consultation, the medication, all doses, monthly delivery, weekly check-ins, and dose adjustments. There is no separate membership fee. First-month pricing applies to new patients on injectable programs only. Cash pay only; we do not bill insurance. HSA and FSA cards are accepted. Cancel anytime with notice; see terms for the required notice period.
Prescription products require an online consultation with a licensed healthcare provider who will determine whether treatment is appropriate. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Individual results vary and are not guaranteed. Treatment is intended for use alongside a reduced-calorie diet and increased physical activity.
Clinician names, photographs, biographies, patient photographs, quotes, figures, and all projection-tool percentages on these pages are placeholders for design review and do not represent real people or verified outcomes. Replace with real, consented material before publication. Dope Doctors is not affiliated with, sponsored by, or endorsed by any brand-name manufacturer, and all trademarks are the property of their respective owners.